|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100050339 |
|
最近更新日期: Date of Last Refreshed on: |
2022-04-03 20:59:55 |
|
注册时间: Date of Registration: |
2021-08-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于“互联网+”的集中群组保健模式对孕晚期女性妊娠压力及分娩结局的干预研究 |
|
Public title: |
Intervention Study on Pregnant Women’s’ Health and Delivery Outcome of the “Internet plus Health Education Program” at Third trimester pregnancy |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于“互联网+”的集中群组保健模式对孕晚期女性妊娠压力及分娩结局的干预研究 |
|
Scientific title: |
Intervention Study on Pregnant Women’s’ Health and Delivery Outcome of the “Internet plus Health Education Program” at Third trimester pregnancy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
胡颖 |
研究负责人: |
周明芳 |
|
Applicant: |
HU YING |
Study leader: |
ZHOU MINGFANG |
|
申请注册联系人电话: Applicant telephone: |
15823223630 |
研究负责人电话: Study leader's telephone: |
18702366551 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
466177156@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
840464797@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
重庆渝北区回兴街道双湖支路1号 |
研究负责人通讯地址: |
重庆渝北区回兴街道双湖支路1号 |
|
Applicant address: |
No. 1, Shuanghu Branch Road, Huixing street, Yubei District, Chongqing |
Study leader's address: |
No. 1, Shuanghu Branch Road, Huixing street, Yubei District, Chongqing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
重庆医科大学附属第三医院 |
||
|
Applicant's institution: |
The Third Affiliated Hospital of Chongqing Medical University |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2021年科伦审第(11)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
重庆医科大学附属第三医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the Third Affiliated Hospital of Chongqing Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
1990-01-01 00:00:00 |
||
|
伦理委员会联系人: |
刘虹妍 |
||
|
Contact Name of the ethic committee: |
LIU HONGYAN |
||
|
伦理委员会联系地址: |
重庆渝北区回兴街道双湖支路1号 |
||
|
Contact Address of the ethic committee: |
No. 1, Shuanghu Branch Road, Huixing street, Yubei District, Chongqing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
重庆医科大学附属第三医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Third Affiliated Hospital of Chongqing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
重庆渝北区回兴街道双湖支路1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1, Shuanghu Branch Road, Huixing street, Yubei District, Chongqing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
重庆市妇幼卫生学会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Chongqing maternal and Child Health Association |
||||||||||||||||||||||
|
Target disease: |
Perinatal health care |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
1.明确孕晚期孕妇妊娠压力的现状及其影响因素。 2.构建基于“互联网+”的集中群组孕期保健模式。 3.明确基于“互联网+”的集中群组孕期保健模式对孕妇妊娠压力及分娩结局的干预效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
1.To clarify the current situation and influencing factors of pregnancy stress in third trimester pregnant women. 2.Constructing a health care model of pregnancy based on Internet plus group. 3.The intervention effect of pregnancy care mode based on Internet plus group on pregnancy pressure and delivery outcome was confirmed. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
纳入标准:①孕周≥28周的孕妇、单胎头位;②B超检查无异常;③无精神和智力障碍,有一定的理解和语言表达能力,能独立完成问卷填写者;④孕妇及其家属知情同意且自愿参加本研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria: ① pregnant women with gestational age ≥ 28 weeks and singleton head position; ② There is no abnormality in B-ultrasound examination; ③ Those who have no mental and intellectual disabilities, have certain understanding and language expression ability, and can complete the questionnaire independently; ④ Pregnant women and their families informed consent and voluntarily participated in this study. |
||||||||||||||||||||||
|
排除标准: |
排除标准:①先兆早产、胎膜早破、宫颈机能不全或子宫颈环扎术后等异常产科情况者;②子痫前期或妊娠期高血压疾病、妊娠合并心脏病等严重内科疾病及妊娠并发症者等。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria: ① abnormal obstetric conditions such as threatened preterm birth, premature rupture of membranes, cervical insufficiency or after cervical cerclage; ② Severe medical diseases such as preeclampsia or pregnancy induced hypertension, pregnancy complicated with heart disease and pregnancy complications. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-08-25 00:00:00至 To 2022-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2021-08-25 00:00:00 至 To 2022-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究者将定期产前检查且符合纳入标准的孕妇作为研究对象,通过孕妇及其家属知情同意后,将自愿参加“互联网+”集中群组保健模式的孕妇纳入干预组,对照组按干预组的年龄、孕周、孕产次、文化程度等信息进行匹配。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The researchers took prenatal care and pregnant women who met the inclusion criteria as the research objects. After the informed consent of the pregnant women and their families, the pregnant women who voluntarily participated in the "Internet plus" group health care model were included in the intervention grou |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2022;发表论文 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2022;publish one’s thesis |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
问卷填写(问卷星),病例(电子)资料收集 数据导入SPSS |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Questionnaire filling and case data collection Data import SPSS |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |